Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Debt to Equity (2020 - 2025)

iBio (IBIO) has disclosed Debt to Equity for 9 consecutive years, with $0.0 as the latest value for Q3 2025.

  • On a quarterly basis, Debt to Equity fell 99.43% to $0.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.0, a 99.43% decrease, with the full-year FY2025 number at $0.01, down 80.57% from a year prior.
  • Debt to Equity was $0.0 for Q3 2025 at iBio, down from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.28 in Q1 2022 to a low of $0.0 in Q3 2025.
  • A 5-year average of $0.07 and a median of $0.04 in 2023 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: surged 85817.32% in 2022, then tumbled 99.43% in 2025.
  • iBio's Debt to Equity stood at $0.24 in 2021, then rose by 14.48% to $0.28 in 2022, then tumbled by 90.64% to $0.03 in 2023, then surged by 120.28% to $0.06 in 2024, then tumbled by 99.5% to $0.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Debt to Equity are $0.0 (Q3 2025), $0.01 (Q2 2025), and $0.01 (Q1 2025).